Table 1.

Participant demographics.

Characteristic	Statistic
Age (years), median (range)	75 (51–82)
Sex
Female	5
Male	4
Race
White	9
Care partner available at home	4
# comorbidities, median (range)	5 (0–11)
# medications, median (range)	6 (2–17)
# PD medications, median (range)∗	1 (0–2)
0	1
1	5
2	3
# dosing times/24 hours
2	2
3	6
4	1

^∗Medication details: participant 1: carbidopa/levodopa and rasagiline, participants 2, 4, 5, and 7: carbidopa/levodopa, participant 3: carbidopa/levodopa and ropinirole, participant 6: none, participant 8: carbidopa/levodopa and cyclobenzaprine, and participant 9: pramipexole.